e-learning
resources
Paris 2018
Sunday, 16.09.2018
Epidemiology of asthma and allergy: prevalence, incidence and risk factors
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
An observational study to characterize severe eosinophilic asthma in New Zealand
S. Shantakumar (Singapore, Singapore), Y. Ho (Singapore, Singapore), J. Beale (Auckland, New Zealand), B. Gribben (Auckland, New Zealand)
Source:
International Congress 2018 – Epidemiology of asthma and allergy: prevalence, incidence and risk factors
Session:
Epidemiology of asthma and allergy: prevalence, incidence and risk factors
Session type:
Thematic Poster
Number:
1155
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Shantakumar (Singapore, Singapore), Y. Ho (Singapore, Singapore), J. Beale (Auckland, New Zealand), B. Gribben (Auckland, New Zealand). An observational study to characterize severe eosinophilic asthma in New Zealand. 1155
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
A retrospective observational study to characterize severe eosinophilic asthma in Taiwan
Source: International Congress 2018 – Asthma and allergy in adults and children and their biomarkers
Year: 2018
Cross-sectional, observational study to estimate the prevalence of the eosinophilic phenotype for Brazilian patients with severe asthma: the BRAEOS study
Source: Virtual Congress 2020 – Clinical characteristics and diagnostic tools for phenotyping asthma and COPD
Year: 2020
Development of asthma in patients with eosinophilic bronchitis: prospective follow up study
Source: Eur Respir J 2002; 20: Suppl. 38, 51s
Year: 2002
Antibiotic use and the development of asthma in a New Zealand birth cohort
Source: Annual Congress 2006 - Highlights of asthma epidemiology
Year: 2006
A single-center observational study assessing response to mepolizumab in severe eosinophilic asthma
Source: International Congress 2019 – Real-world experience of monoclonal antibodies in asthma
Year: 2019
Association of asthma diagnosis with chronic airflow obstruction: a multi-site cross-sectional study
Source: Virtual Congress 2021 – Asthma burden and management I
Year: 2021
Mepolizumab is effective in severe eosinophilic asthmatics: an Austrian real-life study.
Source: Virtual Congress 2020 – Monoclonal antibodies in asthma
Year: 2020
New treatments in severe paediatric asthma
Source: International Congress 2017 – PG7 Paediatric asthma
Year: 2017
Relevance of cat allergen to allergic asthma and rhinitis symptoms among 5 year old children in a New York City birth cohort
Source: Eur Respir J 2005; 26: Suppl. 49, 262s
Year: 2005
Characteristics of asthma patients with frequent exacerbations – an observational study in Sweden
Source: International Congress 2017 – Primary care management of asthma and self-management of respiratory disease
Year: 2017
Effectiveness of omalizumab in Canadian patients with allergic asthma: A retrospective study.
Source: International Congress 2017 – Asthma and allergy: from the bench to the bedside
Year: 2017
Traffic exposure associated with allergic asthma and allergic rhinitis in adults. A cross-sectional study in southern Sweden
Source: Annual Congress 2009 - Indoor and outdoor air pollution
Year: 2009
Clinical and inflammatory characteristics of the European U-BIOPRED adult severe asthma cohort
Source: Eur Respir J 2015; 46: 1308-1321
Year: 2015
Characterisation of eosinophilic bronchiectasis: A European multicohort study
Source: Virtual Congress 2021 – Bronchiectasis heterogeneity: assessing the endotypes
Year: 2021
New instrument of mild asthma management
Source: Annual Congress 2010 - Medical education
Year: 2010
Examining asthma incidence in an Australian prospective cohort: the North West Adelaide health study
Source: Eur Respir J 2006; 28: Suppl. 50, 238s
Year: 2006
Phenotypes of symptomatic airways disease in China and New Zealand
Source: Eur Respir J, 50 (6) 1700957; 10.1183/13993003.00957-2017
Year: 2017
Characteristics of children with asthma and blood eosinophilia: an observational study
Source: Virtual Congress 2021 – Biomarkers and risk factors in childhood asthma
Year: 2021
Sex-specific development of allergic rhinitis among farm children – A cohort study
Source: International Congress 2015 – Understanding paediatric asthma and allergy: genetics and environment
Year: 2015
A large-scale population-based cohort study of idiopathic interstitial pneumonia in Japan
Source: International Congress 2017 – Respiratory epidemiology: from sarcoidosis to respiratory infections and tuberculosis
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept